Montelukast Sodium Tablet, Film Coated
Product Images NDC 43063-762

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 43063-762). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (43063762)

Montelukast Sodium USP 10 mg film-coated tablets packaging label from PD-Rx Pharmaceuticals, Inc. The label states a package size of 30 tablets with NDC 43063-762-30. It includes lot number A21F04 and expiration date 01/2023. Directions for use and safety warnings are partially visible on the label.*

FDA Label Image

Image Of Figure 1 (Montelukast Fig1)

A line graph displaying the mean percent change from baseline over weeks in treatment comparing Montelukast Sodium Tablets (10 mg) versus placebo. The x-axis represents weeks in treatment from 0 to 15, including a washout period after week 12, and the y-axis shows mean percent change. Montelukast Sodium Tablets demonstrate a greater increase compared to placebo throughout the treatment period.*

FDA Label Image

Image Of Chemical Structure (Montelukast Str)

Chemical structure of Montelukast Sodium, showing its molecular components including chlorine, sulfur, a cyclopropyl group, and carboxylate sodium ion.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.